LAFAYETTE, LOUISIANA–(Marketwired – May 25, 2016) –
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN
Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a healthcare service companies in the US, announced today that it will post its full financial results for FY 2016 Q2 on SEDAR on Thursday, May 26, 2016 in advance of its Quarterly Conference Call.
PHM’s Quarterly conference will review the quarter and update the market on plans for 2016 and beyond at 4p.m. EST on Thursday, May 26, 2016.
Conference Call Details
Participants from PHM will include Casey Hoyt (CEO) and Todd Zehnder (Vice President – Finance).
| The details of the call are: | |
| Thursday, May 26, 2016 at 4p.m. EST | |
| US & Canada Toll Free: | |
| Dial In: (855) 886-8711 | |
| Meeting ID Number: 202 143 29 | |
Financial professionals are invited to call in to register 24 hours in advance to ask questions. To pre-register as a qualified caller, please e-mail investorinfo@myphm.com by 5 p.m. EST Wednesday, May 25, 2016.
About PHM
The explosive growth in the number of elderly patients in the US healthcare market is creating pressure to provide more efficient delivery systems. Healthcare providers, such as hospitals, physicians and pharmacies, are seeking partners that can offer a range of products and services that improve outcomes, reduce hospital readmissions, and help control costs. PHM fills this need by delivering a growing number of specialized products and services to achieve these goals. PHM is company that serves patients with heart disease and other chronic health conditions, this operation is a platform for acquisitions and organic growth. PHM is focused on a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. PHM’s post acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
Information in this news release that is not current or historical factual information may constitute forward-looking information within the meaning of securities laws. Implicit in this information, particularly in respect of the future outlook of PHM and anticipated events or results, are assumptions based on beliefs of PHM’s senior management as well as information currently available to it. While these assumptions were considered reasonable by PHM at the time of preparation, they may prove to be incorrect. Readers are cautioned that actual results are subject to a number of risks and uncertainties, including the availability of funds and resources to pursue operations, decline of reimbursement rates, dependence on few payors, possible new drug discoveries, a novel business model, dependence on key suppliers, granting of permits and licenses in a highly regulated business, competition, difficulty integrating newly acquired businesses, low profit market segments as well as general economic, market and business conditions, and could differ materially from what is currently expected. This press release refers non-GAAP and non-IFRS financial measures that do not have standardized meaning prescribed by GAAP or IFRS. PHM’s presentation of these financial measures may not be comparable to similarly titled measures used by other companies. These financial measures are intended to provide additional information to investors concerning PHM’s performance.
Jay Hoffman
Chief Strategy Officer & Investor Relations
(337) 500-1913
Investorinfo@myphm.com
www.phmcompanies.com